Multicenter, double-blind, placebo-controlled, fixed dose evaluation of the safety, efficacy and tolerability of Lamictal (lamotrigine) in the treatment of a major depressive episode in patients with type I bipolar disorder (summary report of trial SCA40910, updated 2005, 6 pp) - Glaxo-SmithKline Corporation
(accessed 1 March 2013)